IRIS
FILIPPI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 56.940
EU - Europa 54.970
AS - Asia 52.169
SA - Sud America 12.905
Continente sconosciuto - Info sul continente non disponibili 3.642
AF - Africa 1.094
OC - Oceania 152
AN - Antartide 1
Totale 181.873
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 53.007
RU - Federazione Russa 29.279
SG - Singapore 19.632
CN - Cina 15.696
BR - Brasile 10.478
IT - Italia 10.440
HK - Hong Kong 6.415
VN - Vietnam 4.836
SE - Svezia 4.702
FR - Francia 2.725
CA - Canada 1.995
DE - Germania 1.915
BD - Bangladesh 1.452
GB - Regno Unito 1.342
IN - India 967
AR - Argentina 964
FI - Finlandia 829
RO - Romania 803
MX - Messico 613
NL - Olanda 551
EC - Ecuador 421
ID - Indonesia 416
AT - Austria 409
ZA - Sudafrica 388
PL - Polonia 370
TR - Turchia 363
ES - Italia 358
IQ - Iraq 347
JP - Giappone 335
IE - Irlanda 303
JM - Giamaica 259
CO - Colombia 237
CR - Costa Rica 222
PY - Paraguay 191
VE - Venezuela 189
PK - Pakistan 177
CL - Cile 169
SA - Arabia Saudita 168
UA - Ucraina 166
MA - Marocco 157
IR - Iran 153
AU - Australia 134
UZ - Uzbekistan 134
MY - Malesia 133
LT - Lituania 132
HN - Honduras 123
AE - Emirati Arabi Uniti 118
PE - Perù 118
NI - Nicaragua 113
TT - Trinidad e Tobago 113
TN - Tunisia 110
GT - Guatemala 99
EG - Egitto 94
CH - Svizzera 92
KE - Kenya 91
SV - El Salvador 90
DZ - Algeria 89
UY - Uruguay 86
PH - Filippine 80
PT - Portogallo 79
IL - Israele 77
BE - Belgio 76
NP - Nepal 76
JO - Giordania 61
KR - Corea 60
CZ - Repubblica Ceca 54
KZ - Kazakistan 54
DO - Repubblica Dominicana 53
AZ - Azerbaigian 50
AL - Albania 47
PR - Porto Rico 47
TW - Taiwan 45
BB - Barbados 44
BO - Bolivia 44
DK - Danimarca 43
OM - Oman 39
TH - Thailandia 39
MD - Moldavia 37
LB - Libano 33
GR - Grecia 32
PA - Panama 32
ET - Etiopia 31
GP - Guadalupe 30
NO - Norvegia 28
KW - Kuwait 26
PS - Palestinian Territory 24
KG - Kirghizistan 23
SN - Senegal 23
BG - Bulgaria 21
CY - Cipro 21
EE - Estonia 21
BH - Bahrain 20
EU - Europa 19
BY - Bielorussia 18
BS - Bahamas 17
CW - ???statistics.table.value.countryCode.CW??? 17
KH - Cambogia 17
RS - Serbia 17
BA - Bosnia-Erzegovina 16
GE - Georgia 16
Totale 177.915
Salva come PNG Salva come JPEG
Città #
Singapore 8.486
Dallas 8.177
Ashburn 7.698
Moscow 6.653
Hong Kong 6.314
San Jose 6.161
Council Bluffs 3.144
Milan 2.822
Shanghai 2.544
Hefei 2.502
Lauterbourg 2.156
Princeton 1.900
Lawrence 1.867
Ho Chi Minh City 1.765
Beijing 1.625
New York 1.419
Hanoi 1.086
Los Angeles 1.080
Santa Clara 956
São Paulo 943
Phoenix 940
Rome 759
Miano 499
Helsinki 476
Carrboro 457
Munich 456
Nuremberg 447
Boardman 442
Montreal 419
Orem 392
Laval 350
Atlanta 345
Rio de Janeiro 330
Naples 316
Chicago 313
Brooklyn 311
Warsaw 296
Denver 288
Dublin 273
North Bergen 262
Tokyo 259
London 251
Toronto 250
Frankfurt am Main 245
Chennai 244
Houston 235
Mexico City 232
Guangzhou 224
Da Nang 219
Johannesburg 217
Washington 206
Belo Horizonte 200
Stockholm 200
Curitiba 194
Brasília 192
Seattle 188
Vienna 188
Boston 185
Poplar 185
The Dalles 182
Manchester 177
Amsterdam 176
Lappeenranta 176
Turin 172
Pune 167
Buffalo 166
San José 165
Haiphong 159
Florence 157
Turku 155
Porto Alegre 150
Tianjin 146
Kingston 145
Biên Hòa 140
Guayaquil 140
Philadelphia 139
Bologna 136
Miami 133
Ankara 132
Shenzhen 130
Salvador 127
Quito 125
Campinas 121
Charlotte 121
Baghdad 117
Tashkent 114
Mumbai 111
Las Vegas 110
Brescia 109
Dhaka 109
San Francisco 109
Managua 107
Fortaleza 101
Genoa 101
Hangzhou 101
Bari 97
Omaha 91
Sydney 91
Ribeirão Preto 90
Hải Dương 87
Totale 87.165
Salva come PNG Salva come JPEG
Nome #
10kin1day: A bottom-up neuroimaging initiative 2.313
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria 564
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 381
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 362
Epidural electrical stimulation facilitates motor recovery in spinal cord injury involving the conus medullaris: A case study 356
Spatial mapping of T-2 and gadolinium-enhancing T-1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis? 324
Multi-Center 3D CNN for Parkinson's disease diagnosis and prognosis using clinical and T1-weighted MRI data 309
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 293
Awareness impairment in Alzheimer's disease and frontotemporal dementia: a systematic MRI review 285
Long-term effectiveness and safety of ocrelizumab: a single-centre real-world study 283
High-frequency epidural electrical stimulation reduces spasticity and facilitates walking recovery in patients with spinal cord injury 282
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 276
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 265
Stool Glial Fibrillary Acidic Protein Is Elevated in Progressive Multiple Sclerosis 242
Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis 237
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 230
Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report 226
Amyloid-Related Imaging Abnormalities and β-Amyloid-Targeting Antibodies: A Systematic Review 214
Functional MRI of the Spinal Cord 204
A common marker of affect recognition dysfunction in the FTD spectrum of disorders 203
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis 203
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 200
Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer’s disease: a real-world study 196
A multicentric investigation of the diagnostic accuracy of cortical lesions and central vein sign in multiple sclerosis 195
Real-word application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohort 192
A novel scoring approach to identify responders to erenumab in clinical practice 191
Application of Deep-Learning to NMOSD and Seronegative Patients with Limited NMOSD Manifestations 191
Dual-task gait training improves cognition and resting-state functional connectivity in Parkinson’s disease with postural instability and gait disorders 190
Action Observation and Motor Imagery Improve Dual Task in Parkinson's Disease: A Clinical/fMRI Study 189
Clinical and neuroanatomical characterization of the semantic behavioral variant of frontotemporal dementia in a multicenter Italian cohort 188
XGBoost vs. TabPFN in Neuroimaging Machine Learning-based analysis 188
Functional correlates of intelligence quotient and cognitive abilities vary according to maturation in pediatric MS 186
MRI biomarkers of freezing of gait development in Parkinson's disease 184
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularization 183
Resting State Functional Connectivity Changes of the Pons in Migraine Patients: A Cross-Sectional and Longitudinal Study 182
Alterations of brain structural MRI are associated with outcome of surgical treatment in trigeminal neuralgia 182
Resting State Effective Connectivity Abnormalities of the Papez Circuit Contribute to Explain Worse Cognitive Performances in Multiple Sclerosis Patients (P1-1.Virtual) 181
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 180
A comparison of MR imaging with fast-FLAIR, HASTE-FLAIR, and EPI-FLAIR sequences in the assessment of patients with multiple sclerosis 180
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 179
A functional MRI study of cortical activations associated with object manipulation in patients with multiple sclerosis 177
Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases 177
The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer’s disease 175
Recognizing Leber’s Hereditary Optic Neuropathy to avoid delayed diagnosis and misdiagnosis 174
Connected Speech Alterations and Progression in Patients With Primary Progressive Aphasia Variants 174
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study 173
Selecting structural MRI predictors of cognitive status in MS patients through a machine learning approach applied to a large multicenter MS population 173
A functional magnetic resonance imaging study of patients with secondary progressive multiple sclerosis 173
Cerebro-cerebellar motor networks in clinical subtypes of Parkinson's disease 171
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci 171
Cognitive and MRI profile in primary and secondary progressive multiple sclerosis 170
2.5-Year changes of connectivity dynamism are relevant for physical and cognitive deterioration in multiple sclerosis 169
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 169
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 168
Functional Connectivity From Disease Epicenters in Frontotemporal Dementia 168
Characterizing 1-Year Development of Cervical Cord Atrophy Across Different Ms Phenotypes: A Voxel-Wise, Multicenter Analysis 168
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 167
A comprehensive update on neuroimaging endpoints in amyotrophic lateral sclerosis 166
Impact of Multiple Sclerosis on Cognitive Aging: A Multicenter Study 166
Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use 166
Correction to: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study (Journal of Neurology, (2024), 271, 11, (7250-7263), 10.1007/s00415-024-12608-6) 166
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 164
A composite score to predict short-term disease activity in patients with relapsing-remitting MS 164
A functional MRI study of cortical activations associated with object manipulation in patients with MS 164
A conventional and magnetization transfer MRI study of the cervical cord in patients with MS 164
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: baseline analyses from the COGEX study 162
A Fully Automatic Method to Segment Choroid Plexuses in Multiple Sclerosis Using Conventional MRI Sequences 160
fMRI of the Sensorimotor System 160
A comparison between the sensitivities of 3-mm and 5-mm thick serial brain MRI for detecting lesion volume changes in patients with multiple sclerosis 160
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study 160
Expanded and independent validation of the NoMoFA scale for Parkinson’s disease: the Italian version 160
Correction to: Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report (Journal of Neurology, (2023), 10.1007/s00415-023-11605-5) 159
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study 159
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder 158
Gray matter damage predicts the accumulation of disability 13 years later in MS. 157
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 156
Neural correlates of bradykinesia in Parkinson’s disease: a kinematic and functional MRI study 156
The association between cognition and motor performance is beyond structural damage in relapsing–remitting multiple sclerosis 155
Effects of atidarsagene autotemcel gene therapy on peripheral nerves in late-infantile metachromatic leukodystrophy 154
A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS 154
A brain MRI study of different types of chronic-progressive multiple sclerosis 154
Phenotypes and clinical subgroups in vestibular migraine: a cross-sectional study with cluster analysis 153
DNA Methylation in the Anti-Mullerian Hormone Gene and the Risk of Disease Activity in Multiple Sclerosis 153
Dynamic functional connectivity of thalamic sub-regions shows divegent patterns in multiple sclerosis phenotypes 153
Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review 153
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis 153
Cognitive phenotypes in multiple sclerosis: mapping the spectrum of impairment 152
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 150
Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gap 149
A comparison of multimodal evoked potentials, nuclear magnetic resonance imaging and CSF profile for the diagnosis of multiple sclerosis. 149
Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: a meta-analysis study 149
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis 148
A 3-Year Magnetic Resonance Imaging Study of Cortical Lesions in Relapse-Onset Multiple Sclerosis 148
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 148
Use of the combination of spirometry, arterial blood gas analysis and overnight oximetry to predict the outcomes of patients affected by motor neuron disease: The Milan-Torin respiratory score (Mi-To-RS) 147
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 147
Combining semi-quantitative rating and automated brain volumetry in MRI evaluation of patients with probable behavioural variant of fronto-temporal dementia: an added value for clinical practise? 146
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 145
A comparison of the sensitivity of monthly unenhanced and enhanced MRI techniques in detecting new multiple sclerosis lesions 144
Amyotrophic Lateral Sclerosis-Frontotemporal Dementia: Shared and Divergent Neural Correlates Across the Clinical Spectrum 144
Totale 21.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.089.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.089.122
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.326 0 0 0 619 45 99 118 79 88 82 89 107
2022/20239.416 4.200 1.746 598 52 119 1.017 313 506 394 80 152 239
2023/20245.317 258 272 457 470 382 972 279 514 123 326 402 862
2024/202531.466 3.538 643 571 673 796 2.196 3.940 2.534 5.807 4.686 3.277 2.805
2025/2026104.462 7.249 8.621 9.175 14.916 6.956 2.984 9.095 7.781 26.379 5.829 2.770 2.707
2026/202728.765 3.692 7.022 6.467 11.584 0 0 0 0 0 0 0 0
Totale 181.873